Details for New Drug Application (NDA): 065100
✉ Email this page to a colleague
NDA 065100 describes PANIXINE DISPERDOSE, which is a drug marketed by Ranbaxy Labs Ltd and is included in one NDA. Additional details are available on the PANIXINE DISPERDOSE profile page.
The generic ingredient in PANIXINE DISPERDOSE is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
The generic ingredient in PANIXINE DISPERDOSE is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
Summary for 065100
| Tradename: | PANIXINE DISPERDOSE |
| Applicant: | Ranbaxy Labs Ltd |
| Ingredient: | cephalexin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065100
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Sep 11, 2003 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, FOR SUSPENSION;ORAL | Strength | EQ 125MG BASE | ||||
| Approval Date: | Sep 11, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
